Clinical trial
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With…
NCT00429065 · Instituto Nacional de Cancerologia de Mexico, Other · Unknown status
Key facts
| NCT number | NCT00429065 |
|---|---|
| Title | Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old. |
| Official title | Selection of Young Patients (< 61 Years), With Good Prognosis Diffuse Large B Cell Lymphoma, According to the Immunophenotype (BCL-6 Negative) to be Treated With Chemoimmunotherapy, With R-CHOP. A Pilot Study. |
| Lead sponsor | Instituto Nacional de Cancerologia de Mexico, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Non-Hodgkin Lymphoma |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 30 |
| Start date | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Jan 31, 2007 |
| Last update posted | Jan 31, 2007 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: